Trikaal Mediinfotech Profile
Key Indicators
- Authorised Capital ₹ 0.60 M
- Paid Up Capital ₹ 0.17 M
- Company Age 18 Year, 28 Days
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -37.24%
- Profit Growth 50.32%
- Ebitda 76.49%
- Net Worth -22.85%
- Total Assets -22.49%
About Trikaal Mediinfotech
Trikaal Mediinfotech Private Limited (TMPL) is a Private Limited Indian Non-Government Company incorporated in India on 03 January 2007 and has a history of 18 years. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.60 M and a paid-up capital of Rs 0.17 M, as per Ministry of Corporate Affairs (MCA) records.
Kalyanasundaram Subramanian, Chandrakant Agrawal, and Dhruv Gulati serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U72200MH2007PTC166687
- Company No.
166687
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Jan 2007
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Trikaal Mediinfotech?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kalyanasundaram Subramanian  | Director | 30-Mar-2021 | Current |
Chandrakant Agrawal  | Director | 26-Mar-2024 | Current |
| Dhruv Gulati | Director | 26-Mar-2024 | Current |
Financial Performance of Trikaal Mediinfotech.
Trikaal Mediinfotech Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 37.24% decrease. The company also saw a substantial improvement in profitability, with a 50.32% increase in profit. The company's net worth observed a substantial decline by a decrease of 22.85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Trikaal Mediinfotech?
In 2017, Trikaal Mediinfotech had a promoter holding of 71.48% and a public holding of 28.52%. The company had 1 Joint Venture. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sun Pharma Laboratories LimitedKalyanasundaram Subramanian is a mutual person
Pharmarack Technologies Private LimitedKalyanasundaram Subramanian and Dhruv Gulati are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Trikaal Mediinfotech?
Trikaal Mediinfotech has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Trikaal Mediinfotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Trikaal Mediinfotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
